Does CERTOLIZUMAB PEGOL Cause Neoplasm malignant? 390 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 390 reports of Neoplasm malignant have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.4% of all adverse event reports for CERTOLIZUMAB PEGOL.
390
Reports of Neoplasm malignant with CERTOLIZUMAB PEGOL
0.4%
of all CERTOLIZUMAB PEGOL reports
29
Deaths
125
Hospitalizations
How Dangerous Is Neoplasm malignant From CERTOLIZUMAB PEGOL?
Of the 390 reports, 29 (7.4%) resulted in death, 125 (32.1%) required hospitalization, and 23 (5.9%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 390 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Neoplasm malignant Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX